Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04474496 · ClinicalTrials.gov registry record
Impact of COVID-19 on Marshallese Communities in the U.S.
A clinical trial, sponsored by University of Arkansas.
- Completed
- Registry status
- 120
- Enrollment target
NCT04474496: Completed study, sponsored by University of Arkansas.
NCT04474496 is a clinical trial that has completed, run by University of Arkansas. The registered enrollment target is 120 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04474496 has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
Marshallese adults in the U.S. will complete an online or telephone survey. This survey will collect data describing the impact of COVID-19 on Marshallese communities. Data collected will help describe: 1) risk exposure, 2) knowledge of preventive recommendations, 3) barriers and facilitators to implementing preventative recommendations, 4) barriers and facilitators to COVID-19 testing when appropriate, and 5) self-care behaviors during COVID-19. Participant inclusion criteria: 1) Self-reported Marshallese; 2) 18 years of age or older; 3) Live in the Continental U.S. or Hawaii.
Primary Outcome
Participants will report behaviors they regularly engage in to lessen their risk of contracting COVID-19 (e.g., social distancing, wearing a mask, etc.). Participants were asked "Which of the following measures have you taken to prevent infection from COVID-19? (Select all that apply)"
Interventions
- OTHER Assessing the impact of COVID-19
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2020-07-27 |
| Est. Completion | 2020-11-30 |
What the finished NCT04474496 record still lists
NCT04474496 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Assessing the impact of COVID-19 is the first listed.
NCT04474496 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04474496 about?
NCT04474496 is a clinical study titled "Impact of COVID-19 on Marshallese Communities in the U.S.". Marshallese adults in the U.S. will complete an online or telephone survey. This survey will collect data describing the impact of COVID-19 on Marshallese communities. Data collected will help describe: 1) risk exposure, 2) knowledge of preventive recommendations, 3) barriers and facilitators to imp...
What is the current status of trial NCT04474496?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2020-07-27. Estimated completion is 2020-11-30.
What interventions are being tested in trial NCT04474496?
The interventions under investigation include: Assessing the impact of COVID-19 (OTHER).
Who is sponsoring clinical trial NCT04474496?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI